Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 150 of 6578 publications.
Carrillo N, Huizing M, Leoyklang P, Quintana M, Shrader J, Bradley K, Slota C, Perreault J, Class B, Ciccone C, Parks R, Joe G, Heiss J, Berry S, Malicdan MC, Gahl W. Open-label phase 2 clinical trial of ManNAc for GNE myopathy. Poster presented at the American Academy of Neurology 71st Annual Meeting; May 6, 2019. Philadelphia, PA.
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AL, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano C, Williams VSL, Vissing J, Zhang Auberson L, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group. Safety and efficacy of intravenous bimagrumab in inclusion body myositis: a phase 2b, randomised, double-blind, placebo-controlled study (RESILIENT). Lancet Neurol. 2019 Apr 12.

Pages